Literature DB >> 31965967

Correlations between disease activity, autoimmunity and biological parameters in patients with chronic spontaneous urticaria.

L de Montjoye1,2, A S Darrigade1, A Giménez-Arnau3, A Herman1,2, L Dumoutier4, M Baeck1,2.   

Abstract

Summary: Background. Biomarkers of disease activity/severity and criteria of autoimmune chronic spontaneous urticaria (CSU) are still a matter of debate. Objective. To investigate possible correlations between clinical and biological markers and their associations with: 1) disease activity, 2) resistance to H1-antihistamines, 3) autoimmunity and 4) autologous serum skin test (ASST) in patients with CSU. To also analyze biological parameter modifications in patients with CSU treated with omalizumab. Materials and methods. Disease activity, H1-antihistamines response and presence of concomitant autoimmune disease were prospectively recorded in 95 patients with CSU. For 60 of them, ASST was performed. Broad biological analysis were performed. Results. C-reactive protein (CRP) serum levels were higher in H1-antihistamines unresponders (p less-than 0.0001) and in more active diseases (p = 0.033). D-dimer plasma levels were higher in H1-antihistamines unresponders (p = 0.008) and in patients with autoimmune status (concomitant autoimmune disease and/or with autoantibodies) (p = 0.016). Total immunoglobuline E (IgE) serum level was lower in patients with positive ASST. Blood basophil counts were lower in patients with CSU and especially in H1-antihistamines unresponders (p = 0.023), in patients with more active disease (p = 0.023), with positive ASST (p = 0.001), and with autoimmune status (p = 0.057). Conversely, under omalizumab, a decrease of CRP (p = 0.0038) and D-dimer serum/plasma levels (p = 0.0002) and an increase of blood basophil counts (p = 0.0023) and total IgE serum levels (p = 0.0007) were observed. Conclusions. This study brings additional evidences of interest to investigate IgE, D-dimer serum/plasma levels and basophil blood counts in patients with CSU as they could be correlated to disease activity, response to treatment and/or autoimmunity.

Entities:  

Keywords:  Autoimmunity; IgE; autologous serum skin test; blood basophil count; chronic spontaneous urticaria

Mesh:

Substances:

Year:  2021        PMID: 31965967     DOI: 10.23822/EurAnnACI.1764-1489.132

Source DB:  PubMed          Journal:  Eur Ann Allergy Clin Immunol        ISSN: 1764-1489


  5 in total

Review 1.  Urticaria: Collegium Internationale Allergologicum (CIA) Update 2020.

Authors:  Marcus Maurer; Kilian Eyerich; Stefanie Eyerich; Marta Ferrer; Jan Gutermuth; Karin Hartmann; Thilo Jakob; Alexander Kapp; Pavel Kolkhir; Désirée Larenas-Linnemann; Hae-Sim Park; Gunnar Pejler; Mario Sánchez-Borges; Knut Schäkel; Dagmar Simon; Hans-Uwe Simon; Karsten Weller; Torsten Zuberbier; Martin Metz
Journal:  Int Arch Allergy Immunol       Date:  2020-03-30       Impact factor: 2.749

Review 2.  Total IgE as a Marker for Chronic Spontaneous Urticaria.

Authors:  Sabine Altrichter; Jie Shen Fok; Qingqing Jiao; Pavel Kolkhir; Polina Pyatilova; Sherezade Moñino Romero; Jörg Scheffel; Frank Siebenhaar; Carolin Steinert; Dorothea Terhorst-Molawi; Yi Kui Xiang; Martin K Church; Marcus Maurer
Journal:  Allergy Asthma Immunol Res       Date:  2021-03       Impact factor: 5.764

3.  Increased serum free IgE levels in patients with chronic spontaneous urticaria (CSU).

Authors:  Jae-Hyuk Jang; Eun-Mi Yang; Youngsoo Lee; Young-Min Ye; Jiyoung Moon; Min Sook Ryu; Hae-Sim Park
Journal:  World Allergy Organ J       Date:  2022-02-12       Impact factor: 4.084

4.  STAT3 gain-of-function is not responsible for low total IgE levels in patients with autoimmune chronic spontaneous urticaria.

Authors:  Merle Sauer; Jörg Scheffel; Stefan Frischbutter; Niklas Mahnke; Marcus Maurer; Thomas Burmeister; Karoline Krause; Martin Metz
Journal:  Front Immunol       Date:  2022-07-19       Impact factor: 8.786

Review 5.  Bruton's tyrosine kinase inhibition-An emerging therapeutic strategy in immune-mediated dermatological conditions.

Authors:  Pedro Mendes-Bastos; Ana Brasileiro; Pavel Kolkhir; Stefan Frischbutter; Jörg Scheffel; Sherezade Moñino-Romero; Marcus Maurer
Journal:  Allergy       Date:  2022-02-28       Impact factor: 14.710

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.